Font Size:
a
A
A
Keyword [TKIs resistance]
Result: 1 - 20 | Page: 1 of 2
1.
Development Of EGFR-TKIs Drug-Resistant NSCLC Cell Lines In Vitro And Investigation On The EGFR-TKIs Resistance Mechanism
2.
Construction And Identification Of Anti-EGFR Single Chain Fragment Antibody(scFv)and Inhibits The Proliferation Of NSCLC Cells And Tumor Growth By ScFv-mediate SiRNA
3.
TOPK Promotes Resistance To EGFR Tyrosine Kinase Inhibitors By Phosphorylating And Activating C-Jun In Lung Cancer
4.
Analysis On Clinical Effect Of CIK Combined With TKIs In Treatment Of Non-small Cell Lung Cancer Patients With TKIs Resistance
5.
Discovery Of A Novel Spliceosome Of ABL Gene(ABL
Δexon7+35INS
) And The Association With TKIs Resistance In Chronic Myeloid Leukemia
6.
EGFR-TKIs Resistance Promotes Immune Escape Of Lung Cancer Cells Through Increasing PD-L1 Expression
7.
The Research Of The Association Between BCR-ABL1 Fusion Gene Mutation And TKIs Resistance Based On Next-generation Sequencing
8.
Study On The Correlation Between C-met Expression And EGFR-TKIs Resistance In Lung Adenocarcinoma
9.
Expressions And Clinical Significance Of Notch1 And IGF-1 In Different EGFR Gene Status Of Non-small Cell Lung Cancer
10.
Acquired EGFR-TKIs Resistance In Non-small Lung Cancer By Lysosomal Deficiency-induced SQSTM1 Accumulation
11.
A Retrospective Study Of The Characteristics Of Chinese Medicine Combined With EGFR-TKIs To Delay The Late NSCLC Resistance Time
12.
Study Of Relation Between PD-L1 Expression And EGFR-TKIs Resistance Mechanism In Non-small Cell Lung Cancer
13.
Inhibition Of Nuclear Factor-kB Improves Sensitivity To Irradiation And EGFR-TKIs,and Decreases Irradiation-induced Lung Toxicity
14.
Molecular Mechanisms Of Tyrosine Kinase Inhibitor Resistance Induced By Cytoplasmic/Nuclear Translocation Of Epidermal Growth Factor Receptor
15.
Mechanisms Of Hedgehog Signaling Pathway To Acquire EGFR-TKIs Resistance In EGFR-mutated Non-small Cell Lung Cancer Patients With Brain Metastasis
16.
Cytoplasmic P120ctn Promotes Tyrosine Kinase Inhibitor Resistance In Lung Cancer Cells By Activating PAKs And Mediated EGFR Downstream Activation
17.
MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
18.
Clinical Study Of Apatinib Mesylate In Treatment Of Advanced Lung Adenocarcinoma With EGFR-TKIs Resistance
19.
Study On EGFR-TKIs Resistance And BIN1 Expression In Lung Adenocarcinoma
20.
The Mechanism Of EGFR-TKIs Resistance In HOTAIR In Non-small Cell Lung Cancer
<<First
<Prev
Next>
Last>>
Jump to